Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observation

Keywords

Chlorambucil, Chronic lymphocytic leukemia, Medicine, Randomization, Stage (stratigraphy)

References

• Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia.A Sawitsky, KR Rai, O Glidewell — 1977
• A clinical staging system for chronic lymphocytic leukemia. Prognostic significanceJ L Binet, M Leporrier, Guillaume Dighiero — 1977
• Does therapy alter the natural history and prognosis of chronic lymphocytic leukemia?William H. Knospe — 1979
• The treatment of chronic lymphocytic leukemia with COP chemotherapyMarcia K. Liepman, May L. Votaw — 1978
• Guidelines for protocol studies in chronic lymphocytic leukemiaRichard T. Silver, Arthur Sawitsky, Kanti Rai — 1978
• Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).Sanford Kempin, B. J. Lee, Howard T. Thaler — 1982
• Studies of leukocyte kinetics in chronic lymphocytic leukemia.T S Zimmerman, Herman A. Godwin, Seymour Perry — 1968
• [Treatment of chronic lymphocytic leukemia].B. Hoerni, G. Simon — 1971
• Clinical staging of chronic lymphocytic leukemia.D. Case — 1977
• Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy.Elizabeth A. Phillips, Sanford Kempin, Sharon Passe — 1977
• Statistical methods for rates and proportionsT. F. de C. Marshall, J. L. Fleiss — 1973
• Combination ChemotherapyT.A. Connors — 1974
• HPR63 Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 VaccinesE. J. Bell, Simon Brassel, H Schirrmacher — 2022
• Statistical Methods for Rates and Proportions.A. Fielding, Joseph L. Fleiss — 1974
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.Richard Peto, M. C. Pike, P. Armitage — 1977

Cited by

• T-small cell disordersElenice Maria Sequetin Cunha, Eliana Monteforte Cassaro Villalobos, Alessandra Figueiredo de Castro Nassar — 2001
• Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trialThierry Priol — 2011
• National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.Cheson Bd, J M Bennett, Michael R. Grever — 1996
• Immunologie de la polypose nasosinusienneClotilde Watelet — 2001
• Expression et fonctionnalité des Toll-Like récepteurs par les cellules de leucémie lymphoïde chronique BCindy Grandjenette — 2008
• Chronic lymphocytic leukemia: new insights into the tumor microenvironment and sensitivity to rationally selected compoundsBeatriz González — 2010
• Clinical prognostic markers in chronic lymphocytic leukemiaStefan Norin — 2011
• Immunological and molecular studies for the development of vaccine therapy for chronic lymphocytic leukemiaMarzia Palma — 2010
• Targeted monoclonal antibody therapy in chronic lymphocytic leukemiaClaes Karlsson — 2010
• T Cells in Patients with B-cell Chronic Lymphocytic Leukemia (B-CLL) and Multiple Myeloma (MM) An Immunological StudyShahryar Kiaii — 2007
• Chronic Lymphocytic LeukemiaStéphane Chèze, M Leporrier — 2002
• New modalities of therapy in chronic lymphocytic leukemia.Bruce D. Cheson — 1991
• Management of Chronic Lymphocytic LeukaemiaNelson Kalil, Bruce D. Cheson — 2000
• Current Treatment for Chronic Lymphocytic LeukemiaValentin Goede, Michael Hallek — 2008
• Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia.Jonni S. Moore, David F. Friedman, Leslie E. Silberstein — 1995
• Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemiaTadeusz Robak, Marek Kasznicki — 2002
• Initial therapy for patients with chronic lymphocytic leukemia.William G. Wierda, Susan M. OʼBrien — 2006
• Chemotherapy of chronic haematological malignancies.Anthony D. Ho — 1991
• Chronic lymphocytic leukemia: when to start treatmentCarlos Chiattone — 2005
• Interferon‐alpha 2b (IFNα) for Early‐Phase Chronic Lymphocytic Leukaemia with High Risk for Disease Progression: Results of a Randomized Multicentre StudyIrmgard Langenmayer, Christoph Nerl, Wolfgang Knauf — 1996

Related papers

• Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.Kanti R. Rai, Bercedis L. Peterson, Frederick R. Appelbaum — 2000
• Chlorambucil and fludarabine as a new pre-transplant conditioning for patients with chronic lymphocytic leukemia: results of in vivo experimentsJaroslava Tomenendálová, Jiřı́ Mayer, Michael Doubek — 2018
• Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia.Mark A. Weiss, T Spiess, Ellin Berman — 1994
• Fludarabine versus chlorambucil: is the debate over?Kanti R. Rai, Angelica Hollweg — 2011
• The Lack of Survival Differences in Randomised Trials in CLL May Be Related to the Effect of Second Line Therapies. A Report from the LRF CLL4 Trial.Daniel Catovsky, Monica Else, Sue Richards — 2006
• First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer — 2009
• Combination therapies for previously untreated CLL.Tait D. Shanafelt, Neil E. Kay — 2007